Abstract
Background
Surgical interventions for cervical esophageal cancer (CEC), particularly larynx-preserving procedures, have not yet been standardized in terms of short- and long-term outcome.
Methods
We retrospectively analyzed 100 consecutive surgeries for CEC in our department. We compared clinicopathological parameters and long-term outcomes between larynx-preserving esophagectomies (LP group) and nonpreserving procedures (NP group). We also evaluated preoperative predictive parameters for larynx-preservation.
Results
Compared with the NP group, the LP group had significantly lower cT (P < 0.001) and cStage (P = 0.001) and shorter tumor length (P = 0.0108). Multivariate logistic regression analysis identified early cT stage, early cStage, and response to preoperative treatment as significant predictive parameters of larynx preservation. Larynx-preserving procedures could be performed for 90.5 % of T1–2 tumors regardless of preoperative treatment response. In contrast in T3–4 tumors, most nonresponders (92.3 %) were ineligible for larynx-preservation (P = 0.0012), whereas 54.3 % of responders could achieve larynx preservation. The average shortening of upward extension in T3–4 tumors after preoperative treatment was 20.0 mm in the LP group vs. 10.2 mm in the NP group (P = 0.051). The two groups were similar in terms of overall morbidity (including pneumonia), mortality, and postoperative hospital days. Importantly, larynx preservation for CEC neither worsened patient prognosis nor increased locoregional recurrence compared to the NP group.
Conclusions
Larynx-preserving esophagectomy for CEC is feasible and oncologically acceptable. The cT, cStage, and clinical response to preoperative treatment are important preoperative predictors of a patient’s suitability for larynx-preservation.
Similar content being viewed by others
References
Laterza E, Mosciaro O, Urso US, Inaspettato G and Cordiano C. Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy. Hepato Gastroenterology. 1994;41:278–82.
Lee DJ, Harris A, Gillette A, Munoz L and Kashima H. Carcinoma of the cervical esophagus: diagnosis, management, and results. South. Med J. 1984;77:1365–7.
NCCN. National comprehensive cancer network clinical practice guidelines in oncology. National Comprehensive Cancer Network, Fort Washington. 2011.
Tong DK, Law S, Kwong DL, Wei WI, Ng RW, Wong KH. Current management of cervical esophageal cancer. World J Surg. 2011;35:600–7.
Wang S, Liao Z, Chen Y, Chang JY, Jeter M, Guerrero T, et al. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience. J Thorac Oncol. 2006;1:252–9.
Uno T, Isobe K, Kawakami H, Ueno N, Shimada H, Matsubara H, et al. Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus. Dis Esophagus. 2007;20:12–8.
Bidoli P, Bajetta E, Stani SC, De CD, Santoro A, Valente M, et al. Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus. Cancer. 2002;94:352–61.
Stuschke M, Stahl M, Wilke H, Walz MK, Oldenburg AR, Stuben G, et al. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus. Oncology. 1999;57:99–105.
Wang HW, Chu PY, Kuo KT, Yang CH, Chang SY, Hsu WH, et al. A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction. J Surg Oncol. 2006;93:468–76.
Ott K, Lordick F, Molls M, Bartels H, Biemer E and Siewert JR. Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus. Br J Surg. 2009;96:258–66.
Kadota H, Sakuraba M, Kimata Y, Hayashi R, Ebihara S, Kato H. Larynx-preserving esophagectomy and jejunal transfer for cervical esophageal carcinoma. Laryngoscope. 2009;119:1274–80.
Sobin L GM, Wittekind C. TNM Classification of malignant tumours, 7th edn. New York: Wiley; 2009.
Makino T, Miyata H, Yamasaki M, Fujiwara Y, Takiguchi S, Nakajima K, et al. Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma. Surgery. 2010;148:908–18.
Makino T, Doki Y, Miyata H, Yasuda T, Yamasaki M, Fujiwara Y, et al. Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma. Surgery. 2008;144:793–802.
Miyata H, Yamasaki M, Takahashi T, Murakami K, Kurokawa Y, Nakajima K, et al. Relevance of [18F]fluorodeoxyglucose positron emission tomography-positive lymph nodes after neoadjuvant chemotherapy for squamous cell oesophageal cancer. Br J Surg. 2013;100:1490–7.
Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Konishi K, et al. Prognostic value of endoscopic biopsy findings after induction chemoradiotherapy with and without surgery for esophageal cancer. Ann Surg. 2011;253:279–84.
Yamasaki M, Miyata H, Tanaka K, Shiraishi O, Motoori M, Peng YF, et al. Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus. Oncology. 2011;80:307–13.
Miyata H, Yamasaki M, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, et al. Larynx-preserving limited resection and free jejunal graft for carcinoma of the cervical esophagus. World J Surg. 2013;37:551–7.
Sun F, Li X, Lei D, Jin T, Liu D, Zhao H, et al. Surgical management of cervical esophageal carcinoma with larynx preservation and reconstruction. Int J Clin Exp Med. 2014;7:2771–8.
Shiozaki H, Tsujinaka T, Inoue M, Yano M, Doki Y, Miyaguchi M, et al. Larynx preservation in surgical treatment of cervical esophageal cancer: combined procedure of laryngeal suspension and cricopharyngeal myotomy. Dis Esophagus. 2000;13:213–8.
Yasuda T, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, et al. Evaluation of dysphagia and diminished airway protection after three-field esophagectomy and a remedy. World J Surg. 2013;37:416–23.
Carlson GW, Schusterman MA and Guillamondegui OM. Total reconstruction of the hypopharynx and cervical esophagus: a 20-year experience. Ann Plast Surg. 1992;29:408–12.
Kakegawa T, Yamana H and Ando N. Analysis of surgical treatment for carcinoma situated in the cervical esophagus. Surgery. 1985;97:150–7.
Mansour KA, Picone AL and Coleman JJ, 3rd. Surgery for high cervical esophageal carcinoma: experience with 11 patients. Ann Thorac Surg. 1990;49:597–601 (discussion 601–2).
Kelley DJ, Wolf R, Shaha AR, Spiro RH, Bains MS, Kraus DH, et al. Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus. Am J Surg. 1995;170:427–31.
Triboulet JP, Mariette C, Chevalier D and Amrouni H. Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases. Arch Surg. 2001;136:1164–70.
Shirakawa Y, Naomoto Y, Noma K, Ono R, Nobuhisa T, Kobayashi M, et al. Free jejunal graft for hypopharyngeal and esophageal reconstruction. Langenbeck’s Arch Surg. 2004;389:387–90.
Bergquist H, Ejnell H, Fogdestam I, Mark H, Mercke C, Lundell L, et al. Functional long-term outcome of a free jejunal transplant reconstruction following chemoradiotherapy and radical resection for hypopharyngeal and proximal oesophageal carcinoma. Digest Surg. 2004;21:426–31 (discussion 432–3).
Daiko H, Hayashi R, Saikawa M, Sakuraba M, Yamazaki M, Miyazaki M, et al. Surgical management of carcinoma of the cervical esophagus. J Surg Oncol. 2007;96:166–72.
Ferahkose Z, Bedirli A, Kerem M, Azili C, Sozuer EM and Akin M. Comparison of free jejunal graft with gastric pull-up reconstruction after resection of hypopharyngeal and cervical esophageal carcinoma. Dis Esophagus. 2008;21:340–5.
Grass GD, Cooper SL, Armeson K, Garrett-Mayer E and Sharma A. Cervical esophageal cancer: a population-based study. Head Neck. 2015;37:808–14.
Huang SH, Lockwood G, Brierley J, Cummings B, Kim J, Wong R, et al. Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Rad Oncol Biol Phys. 2008;71:735–40.
Yamada K, Murakami M, Okamoto Y, Okuno Y, Nakajima T, Kusumi F, et al. Treatment results of radiotherapy for carcinoma of the cervical esophagus. Acta Oncol. 2006;45:1120–5.
Conflict of interest
There are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
10434_2016_5511_MOESM1_ESM.tif
Supplementary material 1 (TIFF 181 kb) Supplemental Fig. 1 Overall survival by classified cT (A) and cStage (B) compared between larynx-preserving versus nonpreserving procedures
Rights and permissions
About this article
Cite this article
Makino, T., Yamasaki, M., Miyazaki, Y. et al. Short- and Long-Term Outcomes of Larynx-Preserving Surgery for Cervical Esophageal Cancer: Analysis of 100 Consecutive Cases. Ann Surg Oncol 23 (Suppl 5), 858–865 (2016). https://doi.org/10.1245/s10434-016-5511-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-016-5511-x